Ome Tad (Omeprazole)

Omeprazole, the active ingredient in Ome Tad, is a proton pump inhibitor presented as a unknown/unknown for oral use. It reduces stomach acid production and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults and children. GNH USA supplies Ome Tad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Ome Tad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ome Tad is a proton‑pump inhibitor that acts on gastric acid secretion pathways.

- Gastro‑esophageal reflux disease: Improves symptom relief and promotes healing of the oesophageal lining. - Peptic ulcer disease: Facilitates ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: Controls excessive gastric acid production associated with the condition. - H‑